Status:
ACTIVE_NOT_RECRUITING
Monitoring Biomarker for Detecting Change in Physical Activity and Limb Function in Inclusion Body Myositis Over Time
Lead Sponsor:
University of Kansas Medical Center
Collaborating Sponsors:
BioSensics
Conditions:
Inclusion Body Myositis
Eligibility:
All Genders
45+ years
Brief Summary
Inclusion-Body Myositis (IBM) results in weakness and the deterioration of distal arm muscles, the symptoms of which are currently assessed through expert examination at clinical visits. Such in-clini...
Eligibility Criteria
Inclusion
- Meet any of the European Neuromuscular Centre Inclusion Body Myositis research diagnostic criteria 2011 categories for IBM.
- Able to provide informed consent.
Exclusion
- Unwillingness to follow study procedures.
- Participation in an investigational drug research study within the past 30 days.
Key Trial Info
Start Date :
November 16 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2027
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT06153108
Start Date
November 16 2023
End Date
December 1 2027
Last Update
July 4 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Kansas Medical Center
Kansas City, Kansas, United States, 66160